Abstract
Purpose
Retrograde cricopharyngeal dysfunction (RCPD) is a disease first described systematically in 2019. The main symptom is inability to belch due to cricopharyngeal muscle dysfunction. Other symptoms include gurgling noises, chest pain, bloating, and excessive flatulence. This paper aims to describe RCPD, the aetiology and diagnosis, treatment options, follow-up, and treatment with botulinum toxin (BT).
Methods
A systematic review was done according to the PRISMA guidelines, using the databases PubMed, Embase, and Cochrane at 8/3/2024. The search combined BT with different descriptions of RCPD. All papers were screened by two authors.
Results
120 papers were identified in the search. After screening 13 papers describing 472 patients in total were included. Mean age was 29.3 years with 51.1% men. Diagnosis was established in 82.4% of the cases by symptomatology, 2.1% by high-resolution manometry, and 15.3% by oesophagoscopy. The mean amount of BT was 66 units (U). Mean follow-up time was 13 months. After 1–4 weeks 93.7% had an effect post-treatment and 81.0% after 6 months. Common symptoms were inability to belch (99.8%), chest pain and/or bloating (95.4%), gurgling noises (84.9%), and excessive flatulence (75.9%). Common complications were mild and transient dysphagia (59.4%) and reflux (35.4%).
Conclusion
The accumulated numbers of patients with RCPD indicates a growing attention to the plausible condition. Injection with BT is a good and safe treatment of RCPD. Most patients only experience mild and transient complications to the treatment. Much is still unknown about RCPD and conditions for setting the diagnosis needs to be evaluated and established internationally.
Similar content being viewed by others
Data availability
The data used for synthesizing data in this review was available from the databases PubMed, Embase and Cochrane.
References
Kahrilas PJ, Dodds WJ, Hogan WJ (1987) Dysfunction of the belch reflex a cause of incapacitating chest pain. Gastroenterology 93:818–840
Bastian RW, Smithson ML (2019) Inability to belch and associated symptoms due to retrograde cricopharyngeus dysfunction: diagnosis and treatment. OTO Open. https://doi.org/10.1177/2473974X19834553
Hoesli RC, Wingo ML, Bastian RW (2020) The long-term efficacy of botulinum toxin injection to treat retrograde cricopharyngeus dysfunction. OTO Open 4(2):1–6. https://doi.org/10.1177/2473974X20938342/FORMAT/EPUB
Wajsberg B, Hoesli RC, Wingo ML, Richardson BE, Bastian RW (2022) Retrograde cricopharyngeus dysfunctionan_ an orphan disease_ (1). Am J Gastroenterol. https://doi.org/10.14309/ajg.0000000000001888
Karagama Y (2021) Abelchia: inability to belch/burp—a new disorder? Retrograde cricopharyngeal dysfunction (RCPD). Eur Arch Otorhinolaryngol 278(12):5087–5091. https://doi.org/10.1007/s00405-021-06790-w
Siddiqui SH, Sagalow ES, Fiorella MA, Jain N, Spiegel JR (2022) Retrograde cricopharyngeus dysfunction: the Jefferson experience. Laryngoscope. https://doi.org/10.1002/lary.30346
Doruk C, Pitman MJ (2023) Lateral transcervical in-office botulinum toxin injection for retrograde cricopharyngeal dysfunction. Laryngoscope. https://doi.org/10.1002/LARY.30871
Oude Nijhuis RAB et al (2022) The inability to belch syndrome: a study using concurrent high-resolution manometry and impedance monitoring. Neurogastroenterol Motility. https://doi.org/10.1111/nmo.14250
Xie M, Wen H, Dou Z (2022) Case report: a case of novel treatment for retrograde cricopharyngeal dysfunction. Front Neurol. https://doi.org/10.3389/FNEUR.2022.1005655
Kahrilas PJ (2022) Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterol Motil 34(5):e14328. https://doi.org/10.1111/NMO.14328
Kahrilas PJ, Dodds WJ, Dent J, Wyman JB, Hogan WJ, Arndorfer RC (1986) Upper esophageal sphincter function during belching. Gastroenterology. https://doi.org/10.1016/0016-5085(86)90449-X
Wajsberg B, Hoesli RC, Wingo ML, Bastian RW (2021) Efficacy and safety of electromyography-guided injection of botulinum toxin to treat retrograde cricopharyngeus dysfunction. OTO Open. https://doi.org/10.1177/2473974X21989587
Alberty J, Oelerich M, Ludwig K, Hartmann S, Stoll W (2000) Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction. Laryngoscope 110(7):1151–1156. https://doi.org/10.1097/00005537-200007000-00016
Regan J, Murphy A, Chiang M, Mcmahon BP, Coughlan T, Walshe M (2014) Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009968.pub2
Hoffman MR, Schiffer B, Patel RA, Smith ME (2022) ‘I’ve never been able to burp’: preliminary description of retrograde cricopharyngeal dysfunction in children ☆. Int J Pediatr Otorhinolaryngol. https://doi.org/10.1016/j.ijporl.2022.111261
Pavesi L et al (2023) Retrograde cricopharyngeus dysfunction effectively treated with low dose botulinum toxin. A case report from Italy. Front Neurol. https://doi.org/10.3389/FNEUR.2023.1238304
Page MJ et al (2020) The Prisma statement: an updated guideline for reporting systematic reviews. BMJ. https://doi.org/10.1136/bmj.n71
“PRISMA.” Accessed: Jan. 02, 2024. http://www.prisma-statement.org/PRISMAStatement/FlowDiagram
Silver JA, Roy CF, Young J, Kost KM (2023) Retrograde cricopharyngeus dysfunction: a Canadian experience fueled by social media. Ear Nose Throat J. https://doi.org/10.1177/01455613231162203
Miller ME, Lina I, O’Dell K, Akst LM (2023) Experiences of patients living with retrograde cricopharyngeal dysfunction. Laryngoscope. https://doi.org/10.1002/LARY.31157
Mitchell M, Denna T, Holdgraf R (2023) The kid who couldn’t burp: the management of a pediatric case of retrograde cricopharyngeal dysfunction. Proc 36(6):755. https://doi.org/10.1080/08998280.2023.2255510
Funding
No funding was received for conducting this study.
Author information
Authors and Affiliations
Contributions
Both authors have contributed to designing the work process behind the review. CHJ (Jönsson) performed the search for relevant papers. Both authors evaluated papers for in- and exclusion. The paper was primarily written by first author CHJ and thereafter evaluated and rewritten together with CCP (Plaschke).
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interests to declare that are relevant to the content of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jönsson, C.H., Plaschke, C.C. Retrograde cricopharyngeal dysfunction and treatment with botulinum toxin: a systematic review. Eur Arch Otorhinolaryngol (2024). https://doi.org/10.1007/s00405-024-08619-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00405-024-08619-8